Table 4.
Antioxidant Activity | ||||||
---|---|---|---|---|---|---|
Extract | PB 0% | PB 30% | PB 50% | PB 70% | PB 90% | Trolox |
DPPH IC50 (µg/mL) |
99.96 ± 0.1 a | 73.11 ± 0.0 b | 49.74 ± 0.1 c | 55.04 ± 0.1 c | 100.1 ± 0.1 a | 10.81 ± 0.1 d |
ABTS IC50 (µg/mL) |
106.61 ± 8.0 a | 89.18 ± 0.9 b | 59.41 ± 2.1 c | 65.57 ± 5.0 c | 112.1 ± 9.5 a | 23.15 ± 4.0 d |
FRAP (mmol Fe2+/g PBE) |
101.9 ± 0.3 a | 112.4 ± 1.4 b | 138.5 ± 4.0 c | 122.9 ± 4.6 d | 101.3 ± 1.2 a | 136.1 ± 1.0 c |
Antihyperglycemic Activity | ||||||
Extract | PB 0% | PB 30% | PB 50% | PB 70% | PB 90% | Acarbose |
α-Amylase IC50 (µg/mL) |
531.5 ± 5.4 a | 536.4 ± 7.1 a | 546.3 ± 2.9 a | 254.2 ± 9.2 b | 300.3 ± 3.9 b | 35.42 ± 1.0 c |
α-Glucosidase IC50 (µg/mL) |
166.2 ± 1.1 a | 132.8 ± 10.8 b | 122.7 ± 11.3 b | 138.4 ± 7.4 b | 162.8 ± 3.7 a | 11000 ± 1.0 c |
Antimicrobial Activity (expressed in zone of inhibition, mm) | ||||||
Extract | PB 0% | PB 30% | PB 50% | PB 70% | PB 90% | LX |
A. brasiliensis | n.d. | n.d. | n.d. | n.d. | n.d. | 12.5 ± 1.2 |
S. cerevisiae | n.d. | n.d. | n.d. | n.d. | n.d. | 39.6 ± 4.2 |
C. albicans | n.d. | n.d. | n.d. | n.d. | n.d. | 24.8 ± 0.0 |
C. perfringens | 12.7 ± 0.2 | 13 ± 0.7 | 13.0 ± 0.2 | 13.0 ± 0.2 | 12.7 ± 0.4 | 18.5 ± 0.8 |
B. cereus | 9.6 ± 0.2 | 10.2 ± 0.0 | 9.9 ± 0.1 | 10.8 ± 0.1 | 10.3 ± 0.2 | 12.5 ± 2.6 |
S. aureus | 9.4 ± 0.2 | 10.1 ± 0.1 | 9.7 ± 0.2 | 10.1 ± 0.3 | 10.2 ± 0.1 | 12.5 ± 0.5 |
L. monocytogenes | 7.4 ± 0.0 | 7.8 ± 0.0 | 7.9 ± 0.6 | 8.7 ± 0.7 | 8.3 ± 0.6 | 9.8 ± 0.3 |
E. coli | n.d. | n.d. | n.d. | n.d. | n.d. | 11.4 ± 0.8 |
Salmonella Enteritidis | n.d. | n.d. | n.d. | n.d. | n.d. | 12.3 ± 1.2 |
Values are expressed as mean ± SD of 3–4 experiments. LX: commercial solution of sodium hypochlorite; n.d.: not detected. Different letters show significant differences (p < 0.05) between groups for the same experiment.